| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 64
| Issue : 3 | Page : 150-158 |
|
|
Scopoletin and umbelliferone from Cortex Mori as protective agents in high glucose-induced mesangial cell as in vitro model of diabetic glomerulosclerosis
Yijun Liang1, Xuxin Zeng1, Jialiang Guo1, Hui Liu1, Bao He2, Renyu Lai3, Quan Zhu2, Zhaoguang Zheng4
1 School of Medicine, Foshan University, Foshan, China
2 The R and D Center of Drug for Renal Diseases, Consun Pharmaceutical Group, Guangzhou, China
3 Foshan Newtopcome Pharmaceutical Technology Co., Ltd., Foshan, China
4 School of Medicine, Foshan University; Foshan Newtopcome Pharmaceutical Technology Co., Ltd., Foshan, China
Correspondence Address:
Dr. Zhaoguang Zheng
School of Medicine, Foshan University, No. 5 Road, Chancheng Area, Foshan; Foshan Newtopcome Pharmaceutical Technology Co., Ltd., No. 129 West Jihua Road, Chancheng Area, Foshan
China
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/cjp.cjp_9_21
|
|
|
Two known coumarins, scopoletin (SP) and umbelliferone (UB), were isolated from Cortex Mori (CM). Their structures were elucidated by various spectroscopic analyses. Then, their effects on rat glomerular mesangial cells (RGMCs, HBZY-1) proliferation, hypertrophy, extracellular matrix (ECM) proliferation, expression of fibronectin, transforming growth factor-beta (TGF-β), and connective tissue growth factor (CTGF) induced by high glucose were studied in vitro model of diabetic glomerulosclerosis. The results show that, CM, SP, and UB can inhibit the RGMCs proliferation to attenuate the ECM proliferation and cell hypertrophy, reduced the accumulation of ECM protein fibronectin, and lowered the expression of the key fibrosis factor TGF-β and CTGF to inhibit the kidney fibrosis and thereby improved diabetic glomerulosclerosis. The two coumarins show great potentialities on treating diabetic glomerulosclerosis, but the animal experiment and mechanism is strongly needed for further proof.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
